Christopher Heelan
Analyst-Equity chez Grantham Mayo Van Otterloo & Co LLC (Research)
Profil
Christopher Heelan currently works at Grantham Mayo Van Otterloo & Co LLC (Research), as Quantitative Research Analyst from 2020.
Dr. Heelan received his graduate degree in 2014 and doctorate degree in 2018 from Brown University and undergraduate degree in 2011 from Vanderbilt University.
Postes actifs de Christopher Heelan
| Sociétés | Poste | Début |
|---|---|---|
Grantham Mayo Van Otterloo & Co LLC (Research)
 Grantham Mayo Van Otterloo & Co LLC (Research) Investment ManagersFinance Grantham, Mayo, Van Otterloo Co. LLC (GMO) is a privately-held global investment management firm and registered investment advisor located in Boston, Massachusetts. The firm provides services to clients in the corporate, public, endowment, and foundation marketplaces. GMO's investment divisions include international active equity, forestry, asset allocation, global fixed-income, emerging equity and quantitative equity. Their research division, GMO Research, provides coverage of a variety of sectors, including but not limited to: health technology, finance, consumer non-durables, energy minerals, technology services and forestry products. | Analyst-Equity | 01/07/2020 |
Formation de Christopher Heelan
| Brown University | Doctorate Degree |
| Vanderbilt University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Grantham Mayo Van Otterloo & Co LLC (Research)
Grantham Mayo Van Otterloo & Co LLC (Research) Investment ManagersFinance Grantham, Mayo, Van Otterloo Co. LLC (GMO) is a privately-held global investment management firm and registered investment advisor located in Boston, Massachusetts. The firm provides services to clients in the corporate, public, endowment, and foundation marketplaces. GMO's investment divisions include international active equity, forestry, asset allocation, global fixed-income, emerging equity and quantitative equity. Their research division, GMO Research, provides coverage of a variety of sectors, including but not limited to: health technology, finance, consumer non-durables, energy minerals, technology services and forestry products. | Finance |
